Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


Latin America, Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market to register a CAGR of 31.0% during the forecast period (2018 - 2024) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, published by KBV research, the LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market would witness market growth of 31.0% CAGR during the forecast period (2018 – 2024).

The Brazil Market held the largest share in the LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2017. The Argentina market is expected to witness a significant CAGR during the forecast period (2018 – 2024).

The Suprachoroidal Space segment is growing at a significant pace in the Saudi Arabia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market during (2018-2024). However, Trabecular Meshwork segment dominated the market in 2017 and is expected to grow at CAGR of 29.4% over the forecast period.

Eye Hospitals among the End Users is dominating the LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2017 and would retain the same trend by 2024; thereby, growing at a CAGR of 30.5% during (2018-2024). Additionally, Ophthalmology Clinics is growing at significant pace during the forecast period.

Full Report: https://www.kbvresearch.com/lamea-minimally-invasive-glaucoma-surgery-migs-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.

LAMEA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation

By Surgery

  • Glaucoma in Conjunction with Cataract
  • Stand Alone Glaucoma 

By Target

  • Suprachoroidal Space
  • Trabecular Meshwork
  • Others

By Product

  • MIGS Stents
  • MIGS Shunts
  • Other

By End User

  • Eye Hospitals
  • Ophthalmology Clinics
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Ellex Medical Lasers Ltd
  • Allergan Plc
  • Santen Pharmaceutical Co., Ltd.
  • Glaukos Corporation
  • Alcon Inc. (Novartis)
  • Lumenis
  • Ivantis, Inc.
  • iSTAR Medical
  • InnFocus Inc.
  • SOLX, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage 
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market



SUBSCRIPTION MODEL